AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,570.00
-170.00 (-2.52%)
Dec 19, 2024, 12:30 PM KST

AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 859.41M KRW in the quarter ending September 30, 2024, with 10,147.51% growth. This brings the company's revenue in the last twelve months to 2.91B, up 5,430.63% year-over-year. In the year 2023, AptaBio Therapeutics had annual revenue of 323.87M with 569.80% growth.

Revenue (ttm)
2.91B
Revenue Growth
+5,430.63%
P/S Ratio
47.67
Revenue / Employee
90.82M
Employees
32
Market Cap
165.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023323.87M275.52M569.80%
Dec 31, 202248.35M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition